Zugl.: Diss. / Includes bibliographical references.

Thesis (M.S.)--University of Wisconsin--Madison, 1966. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.

Thesis (MSc (Veterinary Science))--University of Pretoria, 2006. / Includes bibliographical references.

Orientador: José Luiz Moraes Vasconcelos / Banca: Roberto Sartori Filho / Banca: Guilherme de Paula Nogueira / Resumo: O objetivo desse estudo foi avaliar o efeito das concentrações de progesterona no desenvolvimento folicular e a influência do diâmetro folicular e duração do proestro na concepção de novilhas púberes inseminadas após detecção de cio ou submetidas à IATF. No exp.1, 723 novilhas foram sincronizadas com o protocolo: D0: benzoato de estradiol (BE, 2,0 mg, Estrogin®) + CIDR®; D7: dinoprost trometamina (PGF2a, 12,5 mg, Lutalyse ). As novilhas foram distribuídas aleatoriamente no dia 0 para inserção de CIDR® sem utilização prévia (CIDR1) ou utilizado previamente por 18 dias (CIDR3) e retirada no dia 7 ou dia 9 seguido de detecção de cio e inseminação 12h após o cio. No exp.2, 1083 novilhas foram sincronizadas de acordo com o exp1, entretanto todos dispositivos foram removidos no dia 9 e os animais foram inseminados 48 h (0,5 mg, i.m., ECP® no dia 9), 54 ou 72 h (100 μg, im., Fertagyl® no dia da IATF). No exp.3 474 novilhas foram distribuídas aleatoriamente para receberem: D-1: 2mg de BE no grupo 3; D0: 1 e 2 mg de BE respectivamente nos grupos 1 e 2. Todas novilhas foram sincronizadas com CIDR1, receberam 12,5 mg de PGF2a no dia 7 e 0,5 mg de ECP no dia 9. No grupo 2 foi aplicado 200 UI de eCG no dia 9. As novilhas foram inseminadas 48 horas após a remoção do dispositivo, perfazendo assim 3 grupos experimentais: grupo 1 (1 mg de BE no D0), grupo 2 (200 UI de eCG no D9) e grupo 3 (CIDR por 10 dias). Nos exp.1 e 2 o diâmetro do maior folículo (ØFD) e amostras de sangue (P4) foram obtidas em um subgrupo de animais no dia 7 e dia 9. No dia da IA e IATF foi feita avaliação do ØFD em um subgrupo de animais no exp.3 e em todos animais no exp1 e 2. Amostras de sangue para dosagem de P4 foram colhidas 7 dias após a IA ou IATF em um subgrupo de animais do exp.1 e em todos animais nos... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: The aim of this trial was to evaluate the effect of progesterone concentration in follicular development and influence of follicular diameter and length of proestrus in the conception rate of pos pubertal heifers inseminated after detection of estrus or submitted to TAI. In exp.1, 723 heifers were synchronized with the protocol: D0: estradiol benzoate (EB, 2.0 mg, Estrogin®) + CIDR®; D7: dinoprost trometamina (PGF2a, 12.5 mg, Lutalyse ). The heifers were randomly assigned on D0 for inserting CIDR® without prior use (CIDR1) or previously used for 18 days (CIDR3) and were withdraw on day 7 or day 9 followed by heat detection and insemination 12 hours after estrus. In exp.2, 1083 heifers were synchronized according to exp1, however all devices were removed in day 9 and the animals were inseminated 48h (0.5 mg, i.m., ECP® on day 9), 54 ou 72 h (100 μg, im., Fertagyl® on day TAI). In exp.3, 474 heifers were randomly assigned to receive: D-1: 2 mg of EB in group 3; D0: 1 and 2 mg of EB respectively in groups 1 and 2. All heifers were synchronized with CIDR1, received 12.5 mg of PGF2a on day 7 and 0.5 mg of ECP on day 9. In the group 2 was administered 200 UI of eCG on day 9. The heifers were inseminated 48 hours after device removal, so three experimental groups were formed: group 1 (1 mg of EB on D0), group 2 (200 UI of eCG on D9) and group 3 (CIDR for 10 days). In the exp.1 and 2 the diameter of the largest follicle (ØFD) and sample of blood (P4) were obtained of subset of animals on day 7 and day 9. On days of AI and TAI the diameter of the largest follicle (ØFD) was measured in the subset of animals in the exp.3 and all animals in the exp.1 and exp.2. Blood samples for P4 assays were harvested seven days after AI or TAI in subset of animals the exp.1 and all heifers the exp.2 and exp.3. Pregnancy diagnosis was... (Complete abstract click electronic access below) / Mestre

Los objetivos generales de esta tesis fueron desarrollar nuevos diluyentes de inseminación artificial (IA) suplementados con un análogo de GnRH y caracterizar el proteoma del semen de conejo. En el capítulo I, se evaluó la inclusión de un cóctel de inhibidores de proteasas en el diluyente de inseminación (DI) para evitar parte de la actividad proteasa del plasma seminal de conejo. La calidad seminal y la fertilidad no se vieron afectadas por el cóctel. Sin embargo, la prolificidad fue significativamente menor en el grupo experimental en comparación con los grupos de control positivo y negativo (8,2±0,22 vs. 9,3±0,23 y 9,2±0,26 gazapos por parto, respectivamente). De este capítulo, se puede concluir que la adición de una amplia variedad de inhibidores de proteasas en el diluyente de semen de conejo afecta negativamente la tasa de prolificidad y que en el futuro sería aconsejable probar inhibidores específicos de aminopeptidasas (AMIs). En el capítulo II, suplementamos el DI con AMIs (bestatina y EDTA), y estudiamos su efecto sobre la calidad seminal y el rendimiento reproductivo. La inclusión de AMIs no afectó la calidad seminal, ni la fertilidad (85,3 vs. 88,6%), ni la prolificidad (10,12 vs. 10,51 gazapos por parto) en comparación con el grupo control. Por lo tanto, concluimos que los AMIs se pueden utilizar en los DIs de conejo para inhibir parte de la actividad aminopeptidasa del plasma seminal (PS). En el capítulo III, probamos nuevos DIs de conejo que contenían AMIs con o sin nanopartículas de quitosano (CS)-sulfato de dextrano (DS) que atrapan el análogo de GnRH. Se estudiaron los siguientes diluyentes: C4 (4 µg de buserelina/coneja en medio control (MC): tris-ácido cítrico-glucosa suplementado con AMIs), C5 (5 µg de buserelina/coneja en MC), Q4 (4 µg de buserelina/coneja en nanopartículas CS-DS en MC) y grupo Q5 (5 µg de buserelina/coneja en nanopartículas CS-DS en MC). La fertilidad fue significativamente menor en el grupo C4 en comparación con los grupos C5, Q5 y Q4 (0,7 frente a 0,85, 0,85 y 0,82, respectivamente). Por el contrario, la prolificidad fue similar en los cuatro grupos experimentales. Por lo tanto, las nanopartículas de CS-DS como transportador de acetato de buserelina permiten reducir la concentración de la hormona en diluyentes con AMIs sin afectar la fertilidad ni la prolificidad. Por ello, la nanoencapsulación parece ser un sistema prometedor para proteger el análogo de GnRH en los diluyentes de IA de conejos. Por otro lado, el objetivo de los últimos tres capítulos fue caracterizar las proteínas del semen de conejo. En los capítulos IV y V, se estudiaron las proteínas del PS de conejo. Las muestras de semen se recuperaron utilizando 6 machos de cada línea genética (A y R) y seleccionando una muestra heteroespérmica del comienzo, del medio y del final de cada estación y de cada línea (24 muestras en total). En el capítulo IV, utilizamos la técnica de electroforesis en gel de poliacrilamida 1D. Siete bandas proteicas fueron significativamente diferentes entre las líneas genéticas y tres bandas entre las estaciones. En el capítulo V, se sometió el PS a nano LC-MS/MS y se identificaron y cuantificaron 402 proteínas. 23 proteínas se expresaron diferencialmente entre genotipos. Con respecto al efecto de la estación en el proteoma del PS de conejo, los resultados mostraron que no hubo un patrón claro de variación de proteína a lo largo del año. En el capítulo VI, se caracterizaron las proteínas del espermatozoide de conejo. Se recuperaron 6 muestras espermáticas utilizando 5 machos de cada genotipo y se sometieron a nano LC-MS/MS, identificándose y cuantificándose 487 proteínas. 40 proteínas se expresaron diferencialmente entre genotipos. En conclusión, los resultados de los tres últimos capítulos evidencian que el genotipo está relacionado con una abundancia específica de proteínas del PS y del espermatozoide. Finalmente, se creó la / The general objectives of this thesis were to develop new artificial insemination (AI) extenders supplemented with a GnRH analogue and to characterise the proteomic profile of rabbit semen. In chapter I, the inclusion of a protease inhibitors cocktail in the insemination extender (IE) to avoid part of the rabbit seminal plasma protease activity was evaluated. Seminal quality and fertility rate were not affected by the cocktail, having similar values between experimental and control groups. However, prolificacy rate was significantly lower in experimental group compared to positive and negative control groups (8.2 ±0.22 vs. 9.3 ±0.23 and 9.2 ±0.26 total born per litter, respectively). From this chapter, it may be concluded that the addition of a wide variety of protease inhibitors in the rabbit semen extender negatively affects prolificacy rate and it in the future it would be advisable to test specific aminopeptidase inhibitors (AMIs). Therefore, in chapter II, we supplemented the IE with AMIs (bestatin and EDTA), and we studied their effect on rabbit seminal quality and reproductive performance. Seminal quality was not affected by AMIs. Regarding reproductive performance, the inclusion of AMIs, did not affect fertility (85.3 vs. 88.6%), nor the prolificacy rate (10.12 vs. 10.51 kits per delivery) in comparison with control group. Thus, we concluded that AMIs can be used in rabbit IEs to inhibit part of the seminal plasma aminopeptidase activity. In chapter III, we test new rabbit IEs containing AMIs with or without chitosan (CS)-dextran sulfate (DS) nanoparticles entrapping the GnRH analogue. The following experimental extenders were studied: C4 (4 µg buserelin/doe in control medium (CM): Tris-citric acid-glucose supplemented with AMIs), C5 (5 µg of buserelin/doe in CM), Q4 (4 µg of buserelin/doe into CS-DS nanoparticles in CM) and Q5 group (5 µg of busereline/doe into CS-DS nanoparticles in CM). Results showed that fertility was significantly lower in C4 group compared to C5, Q5 and Q4 groups (0.7 vs. 0.85, 0.85 and 0.82, respectively). On the contrary, prolificacy was similar in the four experimental groups studied. Thus, CS-DS nanoparticles as carrier for buserelin acetate allow reducing the hormone's concentration in extenders supplemented with AMIs without affecting the fertility and prolificacy of rabbit females. Therefore, nanoencapsulation seems to be a promising system to protect the GnRH analogue in rabbit AI extenders. On the other hand, the aim of the last three chapters was to characterize rabbit semen proteins. In chapters IV and V, rabbit seminal plasma (SP) proteins were studied. Semen samples were recovered using 6 males from each genetic line (A and R). For each genotype, one pooled sample at the beginning, middle and end of each season was selected to develop the experiment (24 pools in total). In chapter IV, we used a 1D polyacrylamide gel electrophoresis approach. Seven protein bands were significantly different between genetic lines and three protein bands were significantly different between seasons. In chapter V, SP was subjected nano LC-MS/MS and 402 proteins were identified and quantified. Twenty-three proteins were differentially expressed between genotypes. Regarding the effect of season on rabbit SP proteome, results showed that there was no clear pattern of protein variation throughout the year. The results obtained in both chapters evidence that genotype is related to a specific abundance of SP proteins. In chapter VI, rabbit sperm proteins were characterised. Six samples were recovered during two months using 5 males from each genotype. Sperm proteins were subjected to nano LC-MS/MS and 487 proteins were identified and quantified. Forty proteins were differentially expressed between genotypes. In conclusion, rabbit sperm proteins showed that genotype has also a huge impact on their abundance. Finally, with these data, the first publicly accessible database of rabbit semen proteome was c / Els objectius generals d'aquesta tesi van ser desenvolupar nous diluents d'inseminació artificial (IA) suplementats amb un anàleg de GnRH i caracteritzar el proteoma del semen de conill. En el capítol I, es va avaluar la inclusió d'un còctel d'inhibidors de proteases en el diluent d'inseminació (DI) per evitar part de l'activitat proteasa del plasma seminal de conill. La qualitat seminal i la fertilitat no es van veure afectades pel còctel. No obstant això, la prolificitat va ser significativament menor en el grup experimental en comparació amb els grups de control positiu i negatiu (8,2 ± 0,22 vs. 9,3 ± 0,23 i 9,2 ± 0,26 catxaps per part, respectivament). D'aquest capítol, es pot concloure que l'addició d'una àmplia varietat d'inhibidors de proteases en el diluent de semen de conill afecta negativament la taxa de prolificitat i que en el futur seria aconsellable provar inhibidors específics de aminopeptidasas (AMIS). En el capítol II, suplementàrem el DI amb AMIs (bestatina i EDTA), i vam estudiar el seu efecte sobre la qualitat seminal i el rendiment reproductiu. La inclusió de AMIs no va afectar la qualitat seminal, ni la fertilitat (85,3 vs. 88,6%), ni la prolificitat (10,12 vs. 10,51 catxaps per part) en comparació amb el grup control. Per tant, concloem que els AMIs es poden utilitzar en els DIs de conill per inhibir part de l'activitat aminopeptidasa del plasma seminal (PS). En el capítol III, vam provar nous DIs de conill que contenien AMIs amb o sense nanopartícules de quitosà (CS)-sulfat de dextrà (DS) que atrapen l'anàleg de GnRH. Es van estudiar els següents diluents: C4 (4 µg de buserelina/conilla en medi control (MC): tris-àcid cítric-glucosa suplementat amb AMIs), C5 (5 µg de buserelina/conilla en MC), Q4 (4 µg de buserelina/conilla en nanopartícules CS-DS en MC) i grup Q5 (5 µg de buserelina/conilla en nanopartícules CS-DS en MC). La fertilitat va ser significativament menor en el grup C4 en comparació amb els grups C5, Q5 i Q4 (0,7 enfront de 0,85, 0,85 i 0,82, respectivament). Per contra, la prolificitat va ser similar en els quatre grups experimentals. Per tant, les nanopartícules de CS-DS com a transportador d'acetat de buserelina permeten reduir la concentració de l'hormona en diluents amb AMIs sense afectar la fertilitat ni la prolificitat. Per això, la nanoencapsulació sembla ser un sistema prometedor per protegir l'anàleg de GnRH en els diluents d'IA de conills. D'altra banda, l'objectiu dels últims tres capítols va ser caracteritzar les proteïnes del semen de conill. En els capítols IV i V, es van estudiar les proteïnes del PS de conill. Les mostres de semen es van recuperar utilitzant 6 mascles de cada línia genètica (A i R) i seleccionant una mostra heteroespérmica del començament, del mitjan i del final de cada estació i de cada línia (24 mostres en total). En el capítol IV, utilitzàrem la tècnica d'electroforesi en gel de poliacrilamida 1D. Set bandes proteiques van ser significativament diferents entre les línies genètiques i tres bandes entre les estacions. En el capítol V, es va sotmetre el PS a nano LC-MS / MS i es van identificar i quantificar 402 proteïnes. 23 proteïnes es van expressar diferencialment entre genotips. Pel que fa a l'efecte de l'estació en el proteoma del PS de conill, els resultats van mostrar que no hi havia un patró clar de variació proteica al llarg de l'any. En el capítol VI, es van caracteritzar les proteïnes de l'espermatozoide de conill. Es van recuperar 6 mostres espermàtiques utilitzant 5 mascles de cada genotip i es van sotmetre a nano LC-MS / MS, identificant i quantificant 487 proteïnes. 40 proteïnes es van expressar diferencialment entre genotips. En conclusió, els resultats dels tres últims capítols evidencien que el genotip està relacionat amb una abundància específica de proteïnes del PS i de l'espermatozoide. Finalment, es va crear la primera base de dades d'accés públic del proteoma / Casares Crespo, L. (2018). Development of new artificial insemination extenders supplemented with GnRH analogues to induce ovulation and proteomic characterization of rabbit semen [Tesis doctoral no publicada]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/100854 / TESIS

Purpose - The purpose of the present study is to compare intrauterine msemination (IUI) pregnancy rates (PR) as a function of diagnosis and ovulation protocol utilizing an extended semen transport time. This allowed clients to conveniently collect IUI specimens in the comfort and privacy of their home. A single IUI per treatment cycle was performed. Basic Procedures - Three-hundred-ten consecutive infertilty couples having unexplained, male factor, ovulatory dysfunction, endometriosis, tubal factor or combined diagnostic factors receiving a total of 584 cycles of IUI were included. Ovulation protocols included LH surge, clomiphene citrate (CC)-hCG, CC-gonadotropins(Gn)-hCG, Gn-hCG or leuprolide acetate (L)-Gn-hCG followed 36-42 hours by a single IUI. Pregnancy rates per cycle (fecundity) and per couple (fertility) as a function of diagnosis, ovulation protocol and cycle number were evaluated. In each cycle the couples processed the specimen by adding sperm washing medium at room temperature to the specimen 30 min following collection and allowed it to incubate for two hours prior to IUI during transport. Main Findings - Overall, fecundity was 11.8% (69/584) and fertility was 22.3% (69/310); respectively by diagnosis was: unexplained 22.6%,38.8%; male factor 18.8%,42.9%; ovulatory dysfunction 12.4,22.6%; endometriosis 5.3%,11.1%; tubal factor 7.6%,13.3%; and combined factors 9.7%, 20.0%. Unexplained vs endometriosis (P < 0.0001, P < 0.005), tubal factor (fecundity P < 0.008) and ovulatory dysfunction (fecundity P < 0.027) was statistically different. Male factor vs endometriosis (P < 0.011, P < 0.036) was significantly different. Ovulatory dysfunction vs endometriosis was significantly different (fecundity P < 0.027). Pregnancies by ovulation protocol: LH surge 4.5%,10.5%; CC-hCG 9.4%,14.9%; CC-Gn-hCG 13.7%,23.7%; Gn-hCG 17.5%,45.3%; L-Gn-hCG 3.5%,6.7%. For Gn-hCG vs L-Gn-hCG (P < 0.009, P < 0.030) and LH surge (fecundity P < 0.033). CC-Gn-hCG vs CC-hCG (fertility P < 0.050) and L-Gn-hCG (P < 0.033, P < 0.034). Gn-hCG vs CC-hCG (fecundity P < 0.043). Conclusions - We conclude that IUI is effective when utilizing an extended transport time allowing most couples to collect the specimen at home and is most effective when utilizing Gn-hCG therapy. Based on our analysis, endometriosis, tubal factor and combined diagnostic categories should proceed earlier to higher level assisted reproductive technologies.

To identify factors important to the efficiency of artificial insemination in cattle, four studies were conducted. In the first study, the addition of cream to the inseminate was used in an attempt to increase accessory sperm number. On d 6 after insemination, 60 embryos were evaluated. The addition of cream to the inseminate had no effect on accessory sperm number. In the second study, cryopreserved semen of a marked bull (spermatozoa exhibiting a semi-flattened anterior head) was matched with semen from an unmarked bull (conventional sperm head shape) to determine competitively the effect of a deep uterine insemination on accessory sperm number. Forty embryos were recovered 6 d after insemination and the ratio of accessory sperm observed was different: 62:38 for unmarked semen in the uterine body and marked semen in the uterine horn, and 72:28 for unmarked semen in the uterine horn and marked semen in the uterine body (P < .05). In the third study, superovulated cows were utilized to determine the effect of artificial insemination time on fertilization status and accessory sperm number. Cows were inseminated once at 0 h (n=10), 12 h (n=10), or 24 h (n=10) after the first standing event. On d 6 after insemination, 529 embryos(ova) were recovered. Fertilization rates were 29% (0 h); 60% (12 h); and 81% (24 h)(P < .01). Percentages of embryos with accessory sperm were: 5 (0 h); 8 (12 h); and 41(24 h) (P < .01). In the fourth study, three experiments utilizing superovulated cows were conducted to provide a basis for distinguishing unfertilized ova from very early embryonic death. In Exp. 1, recovered d 6 unfertilized ova were classified morphologically as either: 1) typical, 2) satellite, or 3) fragmented. In Exp. 2, recovered d 6 unfertilized ova from the third study were classified morphologically, and typical ova were fixed. In Exp. 3, ultrastructural features of preovulatory, tubal-stage, and typical d 6 unfertilized ova were investigated. Preovulatory ova revealed normal ultrastructure; tubal-stage ova exhibited evidence of degeneration; typical d 6 ova were degenerated and contained no discernable organelles. The first three studies support the use of accessory sperm evaluation as an alternative measure of fertility. The final study provides a basis from which future embryologists may distinguish fertilization failure from very early embryonic death. / Ph. D.

No description available.

No description available.

Thesis (MScMedSc)--Stellenbosch University, 2013. / ENGLISH ABSTRACT: Male factor infertility is a general term that describes couples in which an inability to conceive is associated with a problem identified in the male partner. Intrauterine insemination (IUI) together with ovulation induction has been shown to be an effective treatment method for male factor infertility. Oocyte production by the ovaries is stimulated by the use of fertility drugs. A prepared sperm sample is then injected into the uterus through the vagina using an IUI catheter which brings the oocytes and spermatozoa into close proximity. Semen preparation is an integral part of an IUI cycle. In a developing country, a simple inexpensive semen preparation method for IUI procedures, not necessitating a lot of equipment, is essential. An example of such a method, the Sep-D Kit (Surelife Sep-D Kit, Surelife Media Technologies Pty Ltd, Singapore) has been proposed as a possible preparation method. In a pilot study performed by the principal investigator (Roxanne Gentis), comparing the Sep-D Kit and standard swim-up preparation methods, it was found that the Sep-D Kit compared very well with the swim-up method regarding most pre- and post-preparation semen parameters. The Sep-D Kit method, however, still needed further testing to see whether or not pregnancy rates resulting from the method are comparable with that resulting from the standard swim-up method, as this ultimately is the required result of an IUI. The primary aim of this study was to compare the Sep-D Kit method to the standard swim-up method with regards to biochemical pregnancy outcome, post-preparation sperm count, motility, total motile count (TMC), morphology, DNA compaction and fragmentation (CMA3 and TUNEL). The secondary aim was to evaluate which variables, male and female, affect biochemical pregnancy outcome. The study took place at Drs Aevitas Fertility Clinic, Vincent Pallotti Hospital, Pinelands. The study was a prospective analytical study and was conducted from December 2010 until October 2012. A total of 473 IUI cycles were evaluated. Results showed that the Sep-D Kit semen preparation method was non-inferior to the standard swim-up method with regards to biochemical pregnancy rates, post-preparation count and TMC. The swim-up method produced samples with a significantly higher post-preparation motility compared to the Sep-D Kit method, however both methods still managed to produce similar biochemical pregnancy rates (10.39% for the swim-up group versus 11.57% for Sep-D Kit group). For the total cohort of cycles analysed the only female parameter which significantly predicted biochemical pregnancy outcome in this study was age. Sperm motility (post-preparation) was the only male parameter that significantly affected biochemical pregnancy outcome. The Sep-D Kit method is more cost effective and also time saving compared to the swim-up method. There is also no need for expensive laboratory equipment or a trained embryologist using the Sep-D Kit preparation method. The Sep-D Kit may therefore be used with confidence as a standard semen preparation method, and may be implemented in developing countries for use in routine IUI procedures. / AFRIKAANSE OPSOMMING: Manlike faktor infertiliteit is 'n algemene term wat gebruik word om paartjies te beskryf wat 'n onvermoë toon om swanger te raak as gevolg van 'n probleem wat geassosieer word met die man. Die kombinasie van intra-uteriene inseminasie (IUI) en ovulasie induksie kan doeltreffend gebruik word om manlike faktor infertiliteit te behandel. Vrugbaarheidsmiddels word gebruik om oösietproduksie in die die eierstokke te stimuleer en 'n voorbereide spermmonster word dan transvaginaal in die baarmoeder ingespuit om sodoende die spermatozoa en oösiete na-aan mekaar te bring. Semenvoorbereiding is 'n integrale deel van 'n IUI siklus en in 'n ontwikkelende land is 'n eenvoudige, goedkoop semenvoorbereidingsmetode – wat die gebruik van duur toerusting uitsluit – noodsaaklik. Die Sep-D Kit metode (Surelife Sep-D Kit, Surelife Media Technologies Pty Ltd, Singapore) is 'n voorbeeld van so 'n voorbereidingsmetode. 'n Loodsstudie, uitgevoer deur die hoofnavorser, (Roxanne Gentis), het gewys dat die Sep-D Kit en standaard opswem voorbereidingmetodes goed vergelyk ten opsigte van meeste semenparameters voor- en na voorbereiding. Dit is egter ook noodsaaklikheid vir verdere navorsing om vas te stel of swangerskapuitkoms na die gebruik van die twee semenvoorbereidingsmetodess vergelykbaar is, aangesien dit die uiteindelike, verlangde uitkoms van 'n IUI is. Die primêre doel van hierdie studie was om die Sep-D Kit metode te vergelyk met die standaard opswemmetode met betrekking tot biochemiese swangerskapuitkoms asook spermtelling, motiliteit, totale motiele spermtelling (TMS), morfologie, DNA kompaksie en fragmentering (CMA3 en TUNEL) na spermvoorbereiding. Die sekondêre doel was om te evalueer watter veranderlikes, manlik en vroulik, die bichemiese swangerskapuitkoms beïnvloed. Die studie is uitgevoer by die Drs Aevitas Fertiliteitskliniek, Vincent Pallotti Hospitaal, Pinelands. Die studie was prospektief analities en het gestrek vanaf Desember 2010 tot en met Oktober 2012. 'n Totaal van 473 IUI siklusse is evalueer en ontleed. Die resultate van die studie het getoon dat die Sep-D Kit semenvoorbereidingsmetode nie ondergeskik aan die opswemmetode was ten opsigte van biochemiese swangerskap, spermtelling en TMS na semenvoorbereiding nie, Spermmotiliteit was betekenisvol hoër vir die opswemmetode vergelykend met die Sep-D Kit, maar ten spite van die verskil was die biochemiese swangerskapsyfers in die twee groepe nie verskillend nie (10.39% in die opswem groep en 11.57% in Sep-D Kit groep). In die totale kohort siklusse wat ontleed is was dit net die ouderdom van die vrou wat 'n betekenisvolle effek op biochemiese swangerskapuitkoms gehad het. Die enigste manlike faktor wat 'n betekenisvolle effek op biochemiese swangerskapuitkoms gehad het was die motiliteit na semenvoorbereiding. Die Sep-D Kit metode is meer koste-effektief en tydbesparend as die standard opswemmetode. Die uitvoer van die Sep-D Kit metode vereis ook ook geen duur apparaat of 'n opgeleide embrioloog nie. Die Sep-D Kit metode kan dus met vertroue gebruik word as 'n standaard semenvoorbereidingsmetode en kan in ontwikkelende lande vir gebruik tydens roetine IUI prosedures geïmplementeer word.